论文部分内容阅读
儿童哮喘发作期症状为咳嗽、喘息、胸闷,重者出现呼吸困难。临床上常首选β_2-受体激动剂来控制哮喘这些症状。但既往所用的这类药或为短效制剂,不利于夜间症状的控制,或因副作用而影响了临床的使用。班布特罗为第一个仅需1d给药1次的口服的β_2-受体激动剂。为观察其疗效及副作用,我们于1999年2月至6月应用班布特罗治疗60例哮喘发作期儿童,取得满意疗效。总结如下。1 临床资料1.1 一般资料 病例选自1999年2月至6月来我科
Children with asthma attack symptoms cough, wheezing, chest tightness, severe dyspnea. Β 2-agonists are often the first choice in clinical practice to control these symptoms of asthma. However, such drugs used in the past or short-acting agents, is not conducive to the control of night symptoms, or because of side effects and affect the clinical use. Bambuterol is the first oral beta 2-receptor agonist to be administered only once a day. In order to observe its curative effect and side effect, we applied bambuterol to treat 60 children with asthma attack from February to June 1999, and achieved satisfactory results. Summarized as follows. 1 Clinical data 1.1 General information The cases selected from February 1999 to June to our department